Asprosin is a novel adipokine which is secreted during fasting conditions and has been found to be increased in the systemic circulation in obesity and other cardio-metabolic diseases [17,23]. The gene discussed is FBN1; the disease is obesity due to melanocortin 4 receptor deficiency.